These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12392200)
21. Use of intrathecal trastuzumab in a patient with carcinomatous meningitis. Laufman LR; Forsthoefel KF Clin Breast Cancer; 2001 Oct; 2(3):235. PubMed ID: 11899418 [No Abstract] [Full Text] [Related]
22. [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel]. Kubo M; Jida M; Yamane M; Miyatani K; Udaka T; Sogabe O; Maeda H; Mizuta M; Shirakawa K Gan To Kagaku Ryoho; 2005 Dec; 32(13):2097-9. PubMed ID: 16352935 [TBL] [Abstract][Full Text] [Related]
23. [Carcinomatous meningitis. Usefulness of spinal fluid cell morphology in the diagnosis of 2 cases]. Barontini F; Catarzi L; Lambruschini P Riv Patol Nerv Ment; 1982; 102(5):227-38. PubMed ID: 7156797 [TBL] [Abstract][Full Text] [Related]
24. CSF carcinoembryonic antigen in meningeal carcinomatosis from breast cancer. Yap BS; Yap HY; Fritsche HA; Blumenschein G; Bodey GP JAMA; 1980 Oct; 244(14):1601-3. PubMed ID: 7420663 [TBL] [Abstract][Full Text] [Related]
25. The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. Straathof CS; de Bruin HG; Dippel DW; Vecht CJ J Neurol; 1999 Sep; 246(9):810-4. PubMed ID: 10525979 [TBL] [Abstract][Full Text] [Related]
26. Metastatic Breast Carcinoma in Cerebrospinal Fluid: A Cytopathological Review of 15 Cases. Rao R; Hoda SA; Marcus A; Hoda RS Breast J; 2017 Jul; 23(4):456-460. PubMed ID: 28117516 [TBL] [Abstract][Full Text] [Related]
28. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer. Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383 [TBL] [Abstract][Full Text] [Related]
29. Meningeal carcinomatosis manifested as bilateral progressive sensorineural hearing loss. Shen TY; Young YH Am J Otol; 2000 Jul; 21(4):510-2. PubMed ID: 10912696 [TBL] [Abstract][Full Text] [Related]
30. Hearing loss in carcinomatous meningitis. Alberts MC; Terrence CF J Laryngol Otol; 1978 Mar; 92(3):233-41. PubMed ID: 632662 [TBL] [Abstract][Full Text] [Related]
31. [Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer]. Hammerer V; Pauli G; Quoix E Bull Cancer; 2005 Nov; 92(11):989-94. PubMed ID: 16316833 [TBL] [Abstract][Full Text] [Related]
32. Acute bilateral sensorineural hearing loss as the presenting symptom of metastatic lung cancer. Snyder MC; Heywood BM Otolaryngol Head Neck Surg; 2001 May; 124(5):592-4. PubMed ID: 11337674 [No Abstract] [Full Text] [Related]
33. [Four cases of meningeal metastasis originating from breast cancer]. Kashiwagi S; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Nakamura M; Kawajiri H; Takashima T; Onoda N; Ishikawa T; Wakasa K; Hirakawa K Gan To Kagaku Ryoho; 2012 Nov; 39(12):1917-9. PubMed ID: 23267929 [TBL] [Abstract][Full Text] [Related]